Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation

NCT07430943 | Recruiting

• 1 other identifier: APRacket
• Study Type: interventional
• Target: 12
• Locations: 1 country
• Sites: 2

Brief Summary

This study looks at whether Street Racket is a feasable activity that can be added to pulmonary rehabilitation for people with chronic lung disease. Participants complete short questionnaires at the start and end of the program to rate the feasibility and rate their breathlessness during each session. Attendance is recorded to understand how well the activity is used and whether there are any barriers.

Conditions

Pulmonary Rehabilitation; Physical Activities; Exercise Therapy

Keywords

pulmonary rehabilitation; street racket; exercise therapy; COPD; ILD; pulmonary hypertension

Outcome Measures

Primary Outcomes (1)

• Acceptability, appropriateness and feasibility of Street Racket

  The primary endpoints acceptability, appropriateness and feasibility will be assessed using patient reported outcomes with the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), \& Feasibility of Intervention Measure (FIM). These instruments have demonstrated strong psychometric properties and will collectively be referred to as the AAF questionnaire. The validated German translation of the AAF, which has also shown reliable and valid psychometric properties will be used in this study. The AAF questionnaire comprises three sections-Acceptability, Appropriateness, and Feasibility-each containing four questions rated on a 5-point Likert scale (1 = Completely disagree, 5 = Completely agree). Scores for each section will be calculated as the mean of the four responses. A mean score above 12 in each section will be considered indicative of a positive result.

  Each at the first training and at the end of the pulmonary rehabilitation (after max. 3 months).

Secondary Outcomes (6)

• Incidence of Treatment-Emergent Adverse Events (Safety and Tolerability)

  After each street racket session, from enrollment until termination of ambulatory pulmonary rehabilitation (max 3 months).

• Adherance rate

  After each street racket session, from enrollment until termination of ambulatory pulmonary rehabilitation (max 3 months).

• Drop-out rate

  After each street racket session, from enrollment until termination of ambulatory pulmonary rehabilitation (max 3 months).

• Perceived dyspnea

  After each street racket session, from enrollment until termination of ambulatory pulmonary rehabilitation (max 3 months).

• Hospital Anxiety and Depression Scale (HADS)

  After each street racket session, from enrollment until termination of ambulatory pulmonary rehabilitation (max 3 months).

Study Arms (1)

Street Racket Arm

EXPERIMENTAL

Street Racket is a ball-and-racket game played on the ground without a net. It resembles table tennis or tennis but is highly flexible, allowing for various playing formats and easy adaptation to individual abilities.

Other: Street Racket

Interventions

Street Racket OTHER

Street racket will be offered as an additional, optional training once session for patients once every two weeks within the ambulatory pulmonary rehabilitation program. The session begins with a 10-minute warm-up led by a physiotherapist, followed by 45 minutes of street racket play. The content of each session will be adapted based on group size and the playing level of the participants. A typical session structure consists of four intervals of 8 minutes of play, each separated by 2-minute breaks, and concludes with 5 minutes of cool-down. Depending on the patients need the training protocol can be adapted, for instance to include more cognitive or balance elements

Street Racket Arm

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Any sex or gender
• Age \>18 years
• Prescribed APR by a physician and currently participating in APR at the USZ
• Physically and psychologically capable of following instructions and standing/walking for up to one hour (short, seated breaks are allowed if needed)

You may not qualify if:

• Require supplemental oxygen therapy that cannot be delivered via a portable backpack system (e.g., large oxygen cylinders on wheels, which pose a fall risk)
• Are unable to follow study procedures due to language barriers, psychological conditions, or orthopaedic limitations that prevent them from standing or walking for up to one hour
• Require walking aids due to impaired balance (e.g., walking sticks, rollator, etc.)

Sponsors & Collaborators

• Mona Lichtblau: lead

Study Sites (2)

Consultant Clinic of Pulmonology, University Hospital of Zurich

Zurich, 8091, Switzerland

NOT YET RECRUITING

Consultant Clinic of Pulmonology, University Hospital of Zurich

Zurich, 8091, Switzerland

RECRUITING

MeSH Terms

Conditions

Motor Activity; Pulmonary Disease, Chronic Obstructive; Hypertension, Pulmonary

Condition Hierarchy (Ancestors)

Behavior; Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Hypertension; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Mona Lichtblau

  University of Zurich

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Mona Lichtblau, PD Dr. med.

CONTACT

+41 442552220; mona.lichtblau@usz.ch

Carmen Wick, Cand. PhD

CONTACT

+41 43 253 44 05; carmen.wick@usz.ch

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Senior Attending Physician, Department of Pulmonology

Study Record Dates

• First Submitted: February 18, 2026
• First Posted: February 24, 2026
• Study Start: March 5, 2026
• Primary Completion (Estimated): February 28, 2027
• Study Completion (Estimated): February 28, 2027
• Last Updated: March 12, 2026

Record last verified: 2026-03

Locations

CH (2)